Health Highlights: March 7, 2012

Here are some of the latest health and medical news developments,
compiled by the editors of HealthDay:

Prices of Seniors’ Drugs Rise Nearly 26
Percent: Report

The cost of medicines used by many older Americans increased nearly 26
percent between 2005 and 2009, according to an AARP report.

The increase was nearly twice the rate of inflation, according to the
analysis of the retail prices of 514 brand name and generic drugs most
commonly used by Medicare recipients, The New York Times reported
Tuesday.

While the prices of generic drugs fell nearly 31 percent during the
study period, the prices of brand name drugs rose by nearly 41 percent,
and the prices of specialty drugs increased by more than 48 percent, AARP
said.

In comparison, the rate of inflation grew by just over 13 percent
between 2005 and 2009, the Times reported.

Drug industry officials criticized the AARP study, and said the
increased availability of generic drugs has slowed the increase in drug
prices in recent years, the newspaper reported.

—–

FDA Sends Warning Letter to Inhalable Caffeine
Maker

A warning letter has been sent to the maker of the inhalable caffeine
product AeroShot, U.S. Food and Drug Administration officials said.

The letter raises questions about the safety of the product and
concerns about how children and teens may use it, the Associated
Press
reported.

AeroShot, which went on sale in January in Massachusetts and New York,
comes in a plastic canister. Consumers put one end of the canister in
their mouths and inhale a fine powder that dissolves.

In the letter, the FDA said the Massachusetts company that makes
AeroShot misled consumers by claiming that the powder can be both inhaled
and ingested, which is not possible, the AP reported.

The FDA is also concerned that people may try to inhale the product
into their lungs, which may not be safe, and noted that the company issued
differing statements on the appropriate age for using AeroShot.

—–

Group Wants FDA to Ban Caramel Coloring in
Sodas

The use of caramel coloring in popular soda drinks such as Coke and
Pepsi should be banned due to a possible cancer risk, the consumer
advocacy group Center for Science in the Public Interest says in a letter
to the U.S. Food and Drug Administration.

In the letter, CSPI says lab tests found that the average level of
4-methylimidazole (4-MI) in 12-ounce servings of regular and diet Coke,
Pepsi, Dr. Pepper and Whole Foods 365 cola was 138 micrograms, far above
the 29 microgram limit recommended by the state of California, the Los
Angeles Times
reported.

The average level of 4-MI indicated a lifetime cancer risk of five out
of 100,000 people, according to the letter. That risk may be higher if
people who don’t drink sodas aren’t included in the calculation.

CSPI says 4-MI — which is formed when sugar is mixed with ammonia and
sulfites to create the caramel coloring that gives colas their familiar
brown color — has been shown to cause lung, liver and thyroid cancer in
mice and rats, the Times reported.

The American Beverage Association said the CSPI letter is a “scare
tactic,” and noted that regulatory agencies worldwide “consider caramel
coloring safe for use in foods and beverages.”

Views: 0

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes